With a revenue increase of 38.63% in the first quarter 2026, year on year to cumulative value of $777 million, Supernus Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,191,462, this marks a new company high.
Within the Healthcare sector Employees of 48 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 508, from total ranking in previous quarter at 665. Supernus Pharmaceuticals Inc has 652 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SUPN Revenue per Employee	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Revenue Change	38.63 %	21.48 %	9.34 %	-1.71 %	4.3 %
Sales per Employee (TTM) $	1,191,462	1,102,687	1,045,305	1,020,130	1,024,535
SUPN's Total Ranking	# 508	# 665	# 455	# 674	# 489
Seq. Revenue Change	-1.83 %	10.13 %	16.11 %	10.43 %	-13.97 %

SUPN Company Profile >> Back to SUPN Efficiency Comparisons >> Compare SUPN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 31
Healthcare Sector	# 49
Overall Market	# 508

Revenue per Employee Statistics
High	Average	Low
$ 1,191,462	$ 636,801	$ 18,434
(Mar 31 2026)		(Dec. 30, 2013)

Financial Statements
Supernus Pharmaceuticals Inc 's Revenue MRQ	$ 208 Millions	Visit SUPN's Income Statement
Supernus Pharmaceuticals Inc 's Revenues TTM	$ 777 Millions	Visit SUPN's aggregate revenue growth
What are SUPN's Sales?		Visit SUPN's Sales by Segment

Other Ratios
Supernus Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SUPN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SUPN's Competitors
Revenue per Employee for SUPN's Suppliers
Revenue per Employee for SUPN's Customers

You may also want to know
SUPN's Sales Growth Rates	SUPN's Pe Price to earnings ratio	SUPN's Receivables Turnover Ratio	SUPN's Stock Quote
SUPN's Net Income Growth Rates	SUPN's Ps Price to Sales ratio	SUPN's Sales per Employee	SUPN's Asset Turnover Ratio
SUPN's Net Margin	SUPN's Pb Price to Book ratio	SUPN's Financial Strength Ratios	SUPN's Dividend Payout Ratio

Date modified: 2026-08-30T14:48:47+00:00

Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Mar 31 2026	Number of Employees Mar 31 2026
Exelixis Inc	2,071,047.08	$ 2,375.491 Million	1,147
Kiniksa Pharmaceuticals International Plc	2,060,232.24	$ 754.045 Million	366
Cormedix Inc	2,040,572.14	$ 389.749 Million	191
Biocryst Pharmaceuticals Inc	2,036,128.74	$ 885.716 Million	435
Eton Pharmaceuticals Inc	1,968,500.00	$ 86.614 Million	44
Assertio Holdings inc	1,927,509.43	$ 102.158 Million	53
Siga Technologies Inc	1,913,809.53	$ 93.777 Million	49
Prestige Consumer Healthcare Inc	1,909,785.96	$ 1,088.578 Million	570
Zevra Therapeutics Inc	1,886,442.62	$ 115.073 Million	61
Incyte Corporation	1,885,028.13	$ 5,361.020 Million	2,844
Privia Health Group Inc	1,832,456.77	$ 2,246.592 Million	1,226
Tg Therapeutics Inc	1,755,260.65	$ 700.349 Million	399
Gilead Sciences Inc	1,749,176.47	$ 29,736.000 Million	17,000
Collegium Pharmaceutical Inc	1,747,635.93	$ 739.250 Million	423
Rigel Pharmaceuticals Inc	1,722,798.85	$ 299.767 Million	174
Alnylam Pharmaceuticals Inc	1,714,769.20	$ 4,286.923 Million	2,500
Atara Biotherapeutics Inc	1,681,428.57	$ 23.540 Million	14
Xenetic Biosciences Inc	1,595,036.50	$ 3.190 Million	2
Soleno Therapeutics Inc	1,565,978.02	$ 285.008 Million	182
Neurocrine Biosciences Inc	1,551,200.00	$ 3,102.400 Million	2,000
Jazz Pharmaceuticals Plc	1,535,863.32	$ 4,438.645 Million	2,890
Mirum Pharmaceuticals Inc	1,531,206.99	$ 569.609 Million	372
Agenus Inc	1,529,209.88	$ 123.866 Million	81
Progyny Inc	1,510,233.64	$ 1,292.760 Million	856
Apellis Pharmaceuticals Inc	1,495,642.76	$ 1,105.280 Million	739
Bristol myers Squibb Company	1,491,753.85	$ 48,482.000 Million	32,500
Fennec Pharmaceuticals Inc	1,457,114.29	$ 50.999 Million	35
Tarsus Pharmaceuticals Inc	1,446,159.46	$ 535.079 Million	370
Eli Lilly And Company	1,444,990.00	$ 72,249.500 Million	50,000
Esperion Therapeutics Inc	1,422,598.64	$ 418.244 Million	294

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.